Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000255701 | SCV000225690 | likely pathogenic | not provided | 2016-04-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000255701 | SCV000321592 | pathogenic | not provided | 2016-07-25 | criteria provided, single submitter | clinical testing | The R420Q missense variant in the EDAR gene has been reported previously in a family with autosomal dominant hypohidrotic ectodermal dysplasia (Monreal et al.,1999). The R420Q variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position in the EDAR death domain (Sabeti et al., 2007) that is conserved across species. Functional studies show that the R420Q variant disrupts NF-kB pathway activation and turns off repression of the Lef-1/b-catenin- dependent transcriptional activity leading to abnormal ectodermal differentiation and hair follicle morphogenesis (Shindo et al., 2004). |
SIB Swiss Institute of Bioinformatics | RCV000755721 | SCV000883203 | pathogenic | Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant | 2018-10-15 | criteria provided, single submitter | curation | This variant is interpreted as Pathogenic, for Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PM6 => Assumed de novo, but without confirmation of paternity and maternity (https://www.ncbi.nlm.nih.gov/pubmed/16435307). PP1 => Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (https://www.ncbi.nlm.nih.gov/pubmed/18231121) (https://www.ncbi.nlm.nih.gov/pubmed/10431241). PM1 => Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation (http://www.uniprot.org/uniprot/Q9UNE0). PS3 => Well-established functional studies show a deleterious effect (https://www.ncbi.nlm.nih.gov/pubmed/11035039). |
Genomic Research Center, |
RCV000755721 | SCV000923715 | likely pathogenic | Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001050412 | SCV001214517 | pathogenic | Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant; Autosomal recessive hypohidrotic ectodermal dysplasia syndrome | 2023-03-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects EDAR function (PMID: 11035039, 15013427). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on EDAR protein function. ClinVar contains an entry for this variant (Variation ID: 5853). This missense change has been observed in individual(s) with autosomal dominant hypohidrotic ectodermal dysplasia (PMID: 10431241, 16435307, 18231121, 20979233, 23401279, 27657131). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 420 of the EDAR protein (p.Arg420Gln). |
Baylor Genetics | RCV001334149 | SCV001526904 | likely pathogenic | Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive | 2018-01-25 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been reported in a family with autosomal dominant hypohidrotic ectodermal dysplasia [PMID: 10431241] and was shown to decrease the EDAR protein's ability to repress the Lef-1/b-catenin activity in vitro [PMID: 15013427] |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000755721 | SCV003799096 | pathogenic | Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant | 2022-10-10 | criteria provided, single submitter | clinical testing | PS3, PS4, PM1, PM2, PP3 |
OMIM | RCV000006211 | SCV000026393 | pathogenic | Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant | 1999-08-01 | no assertion criteria provided | literature only |